NeoKor has commissioned a production facility in Kemerovo specialising in heart valve bioprostheses and other medical devices for cardiovascular surgery. Total investment in the project amounted to 346 million roubles, the federal Industrial Development Fund (IDF) said in a statement. The capacity expansion was needed to supply Russian clinics amid restricted deliveries from Western manufacturers.
Financing was arranged through preferential loans. Of the total, 90 million roubles came from the federal IDF and 10 million roubles from the regional IDF of Kuzbass under the joint Development Projects programme. Another 80 million roubles for the construction of the new facility was provided by SME Bank.
NeoKor CEO Alexander Puz said the company had moved into its own production complex, which would allow it to focus on launching transcatheter heart valve manufacturing and expanding exports to India, Algeria, Cameroon and Central Asian markets.
The company will be able to increase output of heart valve bioprostheses to 4,500 units per year from 2,000 units. In 2027, after completing registration procedures at the new site, it plans to start production of transcatheter heart valves made from animal tissue.
The company’s product portfolio includes, in addition to heart valve bioprostheses for patients with acquired valvular disease, annuloplasty rings for valve repair, cardiovascular patches (used in correcting congenital defects in children) and vascular bioprostheses for lower-limb arterial bypass surgery.
Major customers are leading specialised centres: Almazov National Medical Research Centre, Meshalkin National Medical Research Centre, Far Eastern Federal University, Sukhanov Federal Centre for Cardiovascular Surgery, as well as other state and private clinics.
This is the second project involving the federal IDF in the field of medical devices for cardiovascular surgery. In September 2024, Penza-based MedEng modernised its production, increasing output of unique transcatheter heart valve prostheses by 1.6 times and mechanical full-flow prostheses by 1.2 times. Investment in the upgrade exceeded 300 million roubles, of which 240 million roubles came as a soft loan from the federal IDF.
